BioLineRx Ltd.

Regulatory Filings • Sep 27, 2011

_________ false

C007������� �� ��� ��"�2PublicBIOLINE RX LTD8688Corporation no: 513398750Stock Exchange/Market: ������� �� ���2271428����� 19 , ������� 91450 , ,Tel: 02-5489100 , 02-5489116 Fax: 02-5489101E.mail address: info@BioLineRx.comDate of transmission: 27/09/2011              Time of broadcast: 09:00 08:57:07

Reference: 2011-02-285903

Israel Securities Authority		Tel Aviv Stock Exchange
www.isa.gov.il		www.tase.co.il

Annual General Meeting / Special MeetingRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000Only for corporation incorporated in Israel

On 02/11/2011 at 11:00 the corporation will hold it's special meetingat Yigal Arnon & Co. 1 Azrieli Center, Tel Aviv, IsraelNumber of the security that entitles its holder to vote at the meeting: 1101518The Number - as given by the Tel Aviv Stock Exchange

According to section 182 C of the Companies law, 5759-1999, only shareholders of record at the close of business 03/10/2011 will be entitled to notice of, and to vote at, the Meeting.

Attached hereto is the report Notice_isa.pdf

Attached hereto is the proxy statement Proxy_Nov-02-2011_1101518_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity:
Date of revision of form structure: 04/09/2011
- - -
Name of the Signatory: : Serlin Philip Adam , Position of Signatory in the reporting corporation: Chief Financial Officer , Name of Employer Company: .
Hartum St Telephone: 02-5489100 , Facsimile: 02-5489101 , E-mail: phils@biolinerx.com 2